The Ibn Sina Pharmaceutical Industry Limited announced earnings results for the full year ended June 30, 2019. For the full year, the company announced sales was BDT 5,263.963 million compared to BDT 4,657.350 million a year ago. Operating income was BDT 488.896 million compared to BDT 405.832 million a year ago. Net income was BDT 336.266 million compared to BDT 452.296 million a year ago.